Sofosbuvir-containing regimens are safe and effective in the treatment of HCV patients with moderate to severe renal impairment.
Rasha EletrebyMagdy El-SerafyMahmoud AneesGamal KasemMarwa SalamaReham ElkhoulyMostafa HamdyHisham Abdel HaleemEhab KamalWael Abdel-RazekRabab SalamaMohamed ElshenawyAyman ShafeekMohamed HassanyManal H El-SayedYehia El-ShazlyGamal EsmatPublished in: Liver international : official journal of the International Association for the Study of the Liver (2019)
Sofosbuvir-based regimens are effective and safe for treating patients with chronic HCV and moderate to severe CKD, and in those with associated hepatic decompensation.